South Wales, Oct. 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "VERISIAN" on Aug. 13. The details about the trademark application no. UK00004248758 published in the journal no. 2025/041 (Oct. 10).
With CMS Cameron McKenna Nabarro Olswang LLP as representative, Verisian Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 42 : Scientific and technological services relating to clinical research; software development for trial data analysis and validation; Scientific research and analysis services in the field of pharmaceuticals and biotechnology; Preparation of scientific reports; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research for medical purposes; Provision of scientific information; Software development tools for clinical research; Programming software for importing and managing data; Data management and analytics services for clinical trials; Software as a service (SaaS) featuring software incorporating artificial intelligence (AI) tools for data validation, data analytics, machine learning and artificial intelligence; Software as a service (SaaS) featuring software for clinical trial analysis; Software as a service (SaaS) featuring software for data validation and regulatory submission; Development of databases used in clinical research and data validation; Development, updating and maintenance of artificial intelligence (AI) software and database systems; Development of programmes for data processing; Pharmaceutical research and development; Development of data programs in respect of clinical trial analysis; Technical data analysis; Design and development of computer software for evaluation and calculation of data; Design and development of computer software for regulatory submissions; Data validation services in relation to clinical research; Provision of online platforms for monitoring and reviewing clinical studies; Consultancy services in the field of clinical trial data standardisation and compliance; Consultancy services in the field of drug development and medical research; Consultancy services in the field of clinical research; Scientific validation and oversight for clinical research and trials; Providing information relating to drug development; Provision of information relating to clinical studies and treatments; Consultancy in the field of pharmaceutical research.
Class 44 : Consultancy services in relation to medical regulatory reviews; Medical regulatory review services; Medical analysis services relating to the treatment and validation of clinical trial data; Medical information services provided via digital platforms; Issuing and compilation of medical reports; Monitoring of medical data for medical diagnosis and treatment; Providing pharmaceutical information; Provision of medical data analysis services for diagnostic and treatment purposes; Medical data analysis and validation services to support regulatory submissions and approval; Preparation of medical reports based on biometric and clinical data; Advisory services relating to patient access to clinical innovations; Support services for public health authorities in evaluating medical data.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004248758
Disclaimer: Curated by HT Syndication.
